PYPD
Polypid Ltd.
A clinical-stage biopharmaceutical company in Israel that makes controlled-release medicines delivered right where they're needed. Its PLEX technology wraps drugs in layers of polymers and lipids so they release slowly over weeks; its lead product, D-PLEX100, is an antibiotic that prevents surgical site infections by releasing doxycycline at the wound for a month. Founded in 2008 by Dr. Noam Emanuel, the company's name is a mashup of its own technology—Polymer, Lipid, and Encapsulation matriX.
ISIN: IL0011326795HealthcareIL1 holder
Recent Activity
2022Q2
1 sell
-142.4K shares
-142.4K shares
2022Q1
1 sell
-319.6K shares(-69.2%)
-319.6K shares(-69.2%)
Loading more activity...